PJ, M., MA, P., N, F., M, D., Modrego, P. J., Pina, M. A., . . . Díaz, M. (2006). Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: A nonrandomised controlled trial with magnetic resonance spectroscopy. CNS Drugs, 20(10), 867. https://doi.org/10.2165/00023210-200620100-00006
Chicago Style (17th ed.) CitationPJ, Modrego, Pina MA, Fayed N, Díaz M, Pedro J. Modrego, Miguel A. Pina, Nicolás Fayed, and Marcos Díaz. "Changes in Metabolite Ratios After Treatment with Rivastigmine in Alzheimer's Disease: A Nonrandomised Controlled Trial with Magnetic Resonance Spectroscopy." CNS Drugs 20, no. 10 (2006): 867. https://doi.org/10.2165/00023210-200620100-00006.
MLA (9th ed.) CitationPJ, Modrego, et al. "Changes in Metabolite Ratios After Treatment with Rivastigmine in Alzheimer's Disease: A Nonrandomised Controlled Trial with Magnetic Resonance Spectroscopy." CNS Drugs, vol. 20, no. 10, 2006, p. 867, https://doi.org/10.2165/00023210-200620100-00006.